Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-11-084354
Filing Date
2011-03-31
Accepted
2011-03-31 12:27:00
Documents
7
Period of Report
2010-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 1760416
2 SUBSIDIARIES OF REGISTRANT dex211.htm EX-21.1 870
3 CERTIFICATION OF PRESIDENT AND CEO PURSUANT TO RULE 13A-14(A) dex311.htm EX-31.1 6836
4 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO RULE 13A-14(A) dex312.htm EX-31.2 6858
5 CERTIFICATION OF PRESIDENT AND CEO PURSUANT TO 18 U.S.C. SECTION 1350 dex321.htm EX-32.1 3599
6 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1350 dex322.htm EX-32.2 3618
7 GRAPHIC g166566g83l94.jpg GRAPHIC 32341
  Complete submission text file 0001193125-11-084354.txt   1828104
Mailing Address 5 SYLVAN WAY SUITE 125 PARSIPPANY NJ 07054
Business Address 5 SYLVAN WAY SUITE 125 PARSIPPANY NJ 07054 973-254-3560
Pacira Pharmaceuticals, Inc. (Filer) CIK: 0001396814 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35060 | Film No.: 11724748
SIC: 2834 Pharmaceutical Preparations